Influence of selective estrogen receptor modulators on interleukin-6 expression in human retinal pigment epithelial cells (ARPE-19).

[1]  E. Souied,et al.  [Epidemiology of age related macular degeneration]. , 2009, Journal francais d'ophtalmologie.

[2]  S. Kyrylenko,et al.  Regulation of ERα Signaling Pathway in Neuronal HN10 Cells: Role of Protein Acetylation and Hsp90 , 2008, Neurochemical Research.

[3]  Joe G Hollyfield,et al.  Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.

[4]  A. Salminen,et al.  The effect of 17β-estradiol on IL-6 secretion and NF-κB DNA-binding activity in human retinal pigment epithelial cells , 2007 .

[5]  J. V. van Meurs,et al.  Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. , 2007, Investigative ophthalmology & visual science.

[6]  R. Klein,et al.  Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study. , 2006, Archives of ophthalmology.

[7]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[8]  B. Rosner,et al.  Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.

[9]  G. Abecasis,et al.  Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.

[10]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[11]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-κB , 2005, Trends in Endocrinology & Metabolism.

[12]  B. Munoz,et al.  Hormone Replacement Therapy, Reproductive Factors, and Age-Related Macular Degeneration: The Salisbury Eye Evaluation Project , 2005, Ophthalmic epidemiology.

[13]  C. García-Moreno,et al.  Effects of 17β-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-β1 and insulin-like growth factor-1 in primary human osteoblast cultures , 2004, Journal of endocrinological investigation.

[14]  D. Solit,et al.  Hsp90: the vulnerable chaperone. , 2004, Drug discovery today.

[15]  M. Chin,et al.  Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells , 2004, Journal of Neuroimmunology.

[16]  M. Zarbin Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[17]  A. Maran,et al.  ER-independent actions of estrogen and estrogen metabolites in bone cells. , 2003, Journal of musculoskeletal & neuronal interactions.

[18]  Myles Brown,et al.  Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy , 2003, Breast Cancer Research.

[19]  B. Evans,et al.  Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. , 2003, The Journal of endocrinology.

[20]  L. Hartmann,et al.  Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. , 2003, The New England journal of medicine.

[21]  W. Pratt,et al.  Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery 1 , 2003, Experimental biology and medicine.

[22]  Donald P. McDonnell,et al.  Connections and Regulation of the Human Estrogen Receptor , 2002, Science.

[23]  Myles Brown,et al.  Molecular Determinants for the Tissue Specificity of SERMs , 2002, Science.

[24]  E. Jackson,et al.  Invited Review: Cardiovascular protective effects of 17β-estradiol metabolites , 2001 .

[25]  J. Rakic,et al.  Presence of oestrogen receptor type β in human retina , 2001, The British journal of ophthalmology.

[26]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[27]  D. Farber,et al.  Estrogen receptor in the human eye: influence of gender and age on gene expression. , 1999, Investigative ophthalmology & visual science.

[28]  S. Cowley,et al.  A comparison of transcriptional activation by ERα and ERβ , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  B. Katzenellenbogen,et al.  Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.). , 1998, Endocrinology.

[30]  E. Baulieu,et al.  The 90 kDa heat-shock protein (hsp90) modulates the binding of the oestrogen receptor to its cognate DNA. , 1996, The Biochemical journal.

[31]  L. Hjelmeland,et al.  ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. , 1996, Experimental eye research.

[32]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[33]  A. Salminen,et al.  The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. , 2007, Immunology letters.

[34]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-kappaB. , 2005, Trends in endocrinology and metabolism: TEM.

[35]  R. Schiff,et al.  Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  Scott W Cousins,et al.  Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. , 2003, Investigative ophthalmology & visual science.

[37]  E. Jackson,et al.  Cardiovascular protective effects of 17beta-estradiol metabolites. , 2001, Journal of applied physiology.

[38]  S. Cowley,et al.  A comparison of transcriptional activation by ER alpha and ER beta. , 1999, The Journal of steroid biochemistry and molecular biology.

[39]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.

[40]  J. Gustafsson,et al.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.